29 Sep 2017

Innovative pharmaceutical manufacturing to be launched in Moscow

Share this
To favorites

The planned project will be the first of its kind in Russia implemented under the new legislation on public procurement with suppliers’ reciprocal investment obligations.

On 22 September, the results were announced of a tender to supply medications under which the supplier undertakes to invest in localising pharmaceutical manufacturing in the city.

Biocad CJSC won the right to conclude a unique government contract for a term of 10 years. Under the contract, the city will procure 22 medication brands, mostly oncological agents and immunomodulators. In turn, the investor undertakes, during the first three years, to create capacities for manufacturing, packaging and quality control of medications; for no less than two medications, the investor undertakes to launch end-to-end production, including manufacture of biomaterials.

The principal purpose of the contract is to establish high-tech manufacturing in strict compliance with environmental standards. Long-term procurement of localised products will permit an unprecedented reduction in the price of medications procured. The mechanism is attractive to investors since it guarantees long-term demand for their products.

The newly-established manufacturing unit should meet high environmental safety standards. In addition, the contract stipulates the possibility of replacing currently manufactured and supplied medications with improved analogues.

The tender resulted in a contract worth RUB 14 bn.


In more detail
24 Sep
Moscow Moved Up by 25 Positions in Global Innovation Clusters Ranking
In more detail
23 Sep
Revenue of SMEs Steadily Grows Since June
In more detail
23 Sep
Educational Equipment from Technopolis Moscow SEZ Resident Will Appear in Japanese Schools
Natalya Sergunina on why Moscow does not fear the crisis and what the city’s government is betting on
Uniconf LLC
The Uniconf Holding is the leader on Russia’s confectionery market; it unites 19 Russian confectioneries, including Moscow’s largest enterprises such as Krasny Oktyabr, Babaevsky Confectionery Concern, Rot Front, Russian Chocolates, and several regional companies. They produce all types of confectionery goods: chocolate, chocolate boxed sets, chocolates sold by weight, baked goods (waffles, biscuits, cereals, treacle cakes, cakes), lollipops, marshmallow, toffees, and Oriental sweets.
The iVFarma biotechnological company, based in the Moscow technopark Slava is developing infertility treatment medicines with the entire production cycle, from creating a pharmaceutical substance to producing a ready-made dosage form, carried out exclusively in Russia. OOO iVFarma General Director Mikhail Polzikov, candidate of chemical sciences, was interviewed by Investportal and told us about his company helping Russian families to become happy parents.
All topics